Progyny, Inc. — Director's Dealing 2023

Feb 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Progyny, Inc. (PGNY)
CIK: 0001551306
Period of Report: 2023-02-02

Reporting Person: Schlanger David J (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-02	Common Stock	M	100000	$0.91	Acquired	176168	Direct
2023-02-02	Common Stock	S	61048	$36.12	Disposed	115120	Direct
2023-02-02	Common Stock	S	38952	$36.79	Disposed	76168	Direct
2023-02-03	Common Stock	M	100000	$0.91	Acquired	176168	Direct
2023-02-03	Common Stock	S	94644	$35.51	Disposed	81524	Direct
2023-02-03	Common Stock	S	5356	$36.14	Disposed	76168	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-02	Stock Option (Right to Buy)	$0.91	M	100000	Disposed	2027-08-03	Common Stock (100000.0)	Direct
2023-02-03	Stock Option (Right to Buy)	$0.91	M	100000	Disposed	2027-08-03	Common Stock (100000.0)	Direct

Footnotes

F1: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.46 to $36.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.47 to $37.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.04 to $36.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: These options are fully vested and exercisable.

F7: The amount reported in Column 9 of Table II reflects the Reporting Person's stock option exercise of 1,452 options, which were previously inadvertently omitted, as disclosed in the Reporting Person's Form 4/A filed on February 6, 2023.